BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21442643)

  • 21. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].
    Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 FDG PET images for subcutaneous panniculitis-like T-cell lymphoma.
    Wang SY; Wu YW; Hsiao CH; Li MF; Hsu PY; Yen RF
    Clin Nucl Med; 2011 Jan; 36(1):66-9. PubMed ID: 21157218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
    Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
    J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
    Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
    J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
    Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
    Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
    [No Abstract]   [Full Text] [Related]  

  • 26. Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
    Marzolini M; Wong WL; Ardeshna K; Padhani A; D'Sa S
    Br J Haematol; 2012 Mar; 156(5):557. PubMed ID: 22150023
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary subcutaneous panniculitis-like T-cell cutaneous lymphoma: clinical presentation, treatment and prognosis].
    Lü Z; Shi YK; Zhou LQ; Qin Y; Dong M; Yang JL; Liu P; Zhang CG
    Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):350-3. PubMed ID: 20723432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.
    Wu X; Pertovaara H; Korkola P; Vornanen M; Järvenpää R; Dastidar P; Eskola H; Kellokumpu-Lehtinen PL
    Acta Oncol; 2014 Aug; 53(8):1093-9. PubMed ID: 24960581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Qiao W; Zhao J; Wang C; Wang T; Xing Y
    Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-FDG-PET/CT in lymphoma: two decades of experience.
    Alvarez Páez AM; Nogueiras Alonso JM; Serena Puig A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):340-9. PubMed ID: 22841459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

  • 34. Familial aggregation of subcutaneous panniculitis-like T cell lymphoma: A case report of monozygotic twin brothers.
    Shen XZ; Yu SL; Liu F; Luo ZY
    Medicine (Baltimore); 2020 Oct; 99(42):e22629. PubMed ID: 33080699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
    Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
    J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review.
    Li L; Wu C; Chai Y; Dong C; Zhao L
    Int J Immunopathol Pharmacol; 2021; 35():20587384211009342. PubMed ID: 33845613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous panniculitis-like T-cell lymphoma in a child with trisomy 21.
    Mixon B; Drach L; Monforte H; Barbosa J
    Fetal Pediatr Pathol; 2010; 29(6):380-4. PubMed ID: 21043561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
    Alaibac M; Berti E; Pigozzi B; Chiarion V; Aversa S; Marino F; Peserico A
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S121-3. PubMed ID: 15858508
    [No Abstract]   [Full Text] [Related]  

  • 39. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
    Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
    Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
    [No Abstract]   [Full Text] [Related]  

  • 40. T-cell lymphoma manifesting as a uvular mass.
    Lai WS; Wang CH; Shih CP
    Rheumatology (Oxford); 2013 Apr; 52(4):608. PubMed ID: 23264553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.